Our findings underscore the potential of TNFAIP3-targeted strategies in mitigating COPD–insomnia comorbidity, particularly in the elderly, who are often underrepresented in mechanistic studies yet overrepresented in clinical prevalence. The gene discussed is TNFAIP3; the disease is insomnia measurement.